The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mathew, A.
Right arrow Articles by Kennedy, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mathew, A.
Right arrow Articles by Kennedy, J. S.
The Journal of Immunology, 2005, 174: 2212-2219.
Copyright © 2005 by The American Association of Immunologists

Identification of Murine Poxvirus-Specific CD8+ CTL Epitopes with Distinct Functional Profiles1

Anuja Mathew2, Masanori Terajima, Kim West, Sharone Green, Alan L. Rothman, Francis A. Ennis and Jeffrey S. Kennedy

Center for Infectious Disease and Vaccine Research, University of Massachusetts Medical School, Worcester, MA 01655

Murine T cell epitopes against vaccinia virus (VV) have not been characterized to date in part due to the large and complex genome of VV. We have identified and characterized two CD8+ T cell epitopes on the A47L (modified VV Ankara strain (MVA)-029) and J6R (MVA-043) proteins of VV that are Db and Kb restricted, respectively. Following i.p. immunization with VV New York City Board of Health (NYCBH) strain, MVA-029 peptide-stimulated splenocytes secreted IFN-{gamma} from 7 days to 7 mo postimmunization, and virus-stimulated effectors were also able to lyse MVA-029-pulsed target cells at the same time points. In contrast, MVA-043 peptide-stimulated splenocytes secreted very low levels of IFN-{gamma} only at day 7 but maintained the ability to lyse target cells up to 2 mo postimmunization. Both MVA-029 and MVA-043 peptide-stimulated lymph node cells degranulated similarly as assessed by Ag-induced CD107 expression. T cell responses to whole-virus stimulation remained robust and steady during the acute and memory T cell response to VV. Identification of T cell epitopes on VV will enable further studies to increase our understanding of the role of CD8+ T cells in VV infection and assist in the design of new protective strategies.




This article has been cited by other articles:


Home page
J. Immunol.Home page
V. S. Meyer, W. Kastenmuller, G. Gasteiger, M. Franz-Wachtel, T. Lamkemeyer, H.-G. Rammensee, S. Stevanovic, D. Sigurdardottir, and I. Drexler
Long-Term Immunity against Actual Poxviral HLA Ligands as Identified by Differential Stable Isotope Labeling
J. Immunol., November 1, 2008; 181(9): 6371 - 6383.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. Jing, D. H. Davies, T. M. Chong, S. Chun, C. L. McClurkan, J. Huang, B. T. Story, D. M. Molina, S. Hirst, P. L. Felgner, et al.
An Extremely Diverse CD4 Response to Vaccinia Virus in Humans Is Revealed by Proteome-Wide T-Cell Profiling
J. Virol., July 15, 2008; 82(14): 7120 - 7134.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Q. Jiang, X.-S. He, N. Feng, and H. B. Greenberg
Qualitative and Quantitative Characteristics of Rotavirus-Specific CD8 T Cells Vary Depending on the Route of Infection
J. Virol., July 15, 2008; 82(14): 6812 - 6819.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Oseroff, B. Peters, V. Pasquetto, M. Moutaftsi, J. Sidney, V. Panchanathan, D. C. Tscharke, B. Maillere, H. Grey, and A. Sette
Dissociation between Epitope Hierarchy and Immunoprevalence in CD8 Responses to Vaccinia Virus Western Reserve
J. Immunol., June 1, 2008; 180(11): 7193 - 7202.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Mitra-Kaushik, J. Cruz, L. J. Stern, F. A. Ennis, and M. Terajima
Human Cytotoxic CD4+ T Cells Recognize HLA-DR1-Restricted Epitopes on Vaccinia Virus Proteins A24R and D1R Conserved among Poxviruses
J. Immunol., July 15, 2007; 179(2): 1303 - 1312.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Assarsson, J. Sidney, C. Oseroff, V. Pasquetto, H.-H. Bui, N. Frahm, C. Brander, B. Peters, H. Grey, and A. Sette
A Quantitative Analysis of the Variables Affecting the Repertoire of T Cell Specificities Recognized after Vaccinia Virus Infection
J. Immunol., June 15, 2007; 178(12): 7890 - 7901.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Moutaftsi, H.-H. Bui, B. Peters, J. Sidney, S. Salek-Ardakani, C. Oseroff, V. Pasquetto, S. Crotty, M. Croft, E. J. Lefkowitz, et al.
Vaccinia Virus-Specific CD4+ T Cell Responses Target a Set of Antigens Largely Distinct from Those Targeted by CD8+ T Cell Responses
J. Immunol., June 1, 2007; 178(11): 6814 - 6820.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Cornberg, B. S. Sheridan, F. M. Saccoccio, M. A. Brehm, and L. K. Selin
Protection against Vaccinia Virus Challenge by CD8 Memory T Cells Resolved by Molecular Mimicry
J. Virol., January 15, 2007; 81(2): 934 - 944.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. C. Tscharke, W.-P. Woo, I. G. Sakala, J. Sidney, A. Sette, D. J. Moss, J. R. Bennink, G. Karupiah, and J. W. Yewdell
Poxvirus CD8+ T-Cell Determinants and Cross-Reactivity in BALB/c Mice.
J. Virol., July 1, 2006; 80(13): 6318 - 6323.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. H. Davies, M. M. McCausland, C. Valdez, D. Huynh, J. E. Hernandez, Y. Mu, S. Hirst, L. Villarreal, P. L. Felgner, and S. Crotty
Vaccinia Virus H3L Envelope Protein Is a Major Target of Neutralizing Antibodies in Humans and Elicits Protection against Lethal Challenge in Mice
J. Virol., September 15, 2005; 79(18): 11724 - 11733.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.